Purchase Order 36C24921P0013
- Not listed
- This is a federal contract award from the Department of Veterans Affairs (VA) Veterans Integrated Service Network 17 to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, valued at $203,767.72, is for the provision of CEPHEID TESTING SUPPLIES AND REAGENTS. The contract has no set-aside designation and is a firm fixed price purchase order. Cepheid, a subsidiary of Danaher Corporation, is a leading molecular diagnostics company that has been awarded numerous...
- This federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, is for the delivery of CEPHEID REAGENTS to the Department of Veterans Affairs (VA) Veterans Health Administration, Veterans Integrated Service Network 10. The $111,566.90 firm fixed-price delivery order contract has a completion date of September 7, 2021 and was awarded on February 1, 2020. Cepheid, a subsidiary of the Danaher Corporation, is a major supplier of diagnostic testing products,...
- This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, including tests for infectious diseases and genetic conditions. The contract is valued at $108,996.40 and is for the provision of consumables and reagents for molecular testing to support the VA's clinical testing programs serving veterans. The contract does not have a set-aside designation. Cepheid has been awarded...
- This is a federal contract award from the Department of Veterans Affairs (VA) Veterans Integrated Service Network 23 to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, including tests for infectious diseases and genetic conditions. The contract is for the procurement of reagent tests and consumables, with a ceiling value of $180,605.16. It is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is September 30, 2017. This contract...
- The U.S. Department of Veterans Affairs (VA) has awarded a purchase order contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, to provide emergency Cepheid reagents and consumables. The contract has a firm fixed price, a ceiling value of $152,131.86, and an ultimate completion date of February 20, 2024. This contract does not have a set-aside designation. Cepheid is a leading provider of molecular diagnostic equipment, reagents, and consumables to the VA,...
- This federal contract award, valued at $54,574.86, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 21 to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is a purchase order for the provision of Cepheid reagents and equipment compatible with the VA's existing GeneXpert analyzers. This single-award indefinite delivery vehicle (IDV) enables the VA to continuously procure Cepheid's molecular diagnostic solutions to...
- This firm fixed price purchase order contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, including infectious disease testing products. The contract is for $61,730.25 and has a completion date of September 30, 2024. Cepheid will provide reagents, test kits, and supplies compatible with the Cepheid GeneXpert PCR lab test analysis system to support clinical testing programs serving...
- This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, including tests for infectious diseases and genetic conditions. The contract, valued at $41,103.65, is a delivery order awarded by the Veterans Integrated Service Network 6 (VISN 6) of the U.S. Department of Veterans Affairs (VA) for Cepheid's MOLECULAR DIAGNOSTIC TESTING SYSTEM REAGENTS, ASSAYS, AND LEASE. The contract has an ultimate completion date of March 31, 2025 and is a firm...
- This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 8. The contract is for the delivery of CEPHEID REAGENTS, a Firm Fixed Price Delivery Order with a ceiling value of $997,200.00 and a period of performance ending on June 8, 2026. The contract is not set aside for any specific business type. Cepheid has established itself as a critical provider of molecular...
- This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Department of Veterans Affairs (VA). The contract, with a ceiling value of $1,526,412.82, is a delivery order that will run through January 18, 2025. It is a firm fixed-price contract for the provision of CEPHEID REAGENTS. The contract has no set-aside designation. Cepheid is the prime contractor and has previously been awarded other federal contracts and grants, including...
This is a federal contract award from the Department of Veterans Affairs (VA) Veterans Integrated Service Network 9 to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, with a ceiling value of $88,369.62, is for the procurement of Cepheid reagents, consumables, and supplies for a one-year period. The contract is a firm fixed-price purchase order and does not have a set-aside designation. Cepheid, a subsidiary of the Danaher Corporation, is a leading provider of molecular diagnostic testing equipment, reagents, and consumables to federal agencies, including the VA. Through this and other indefinite delivery contracts, the VA can continuously procure Cepheid's molecular diagnostic solutions to support clinical testing programs serving veterans. Cepheid has been awarded numerous prime federal contracts and has also participated as a subrecipient on federal grant-funded projects related to infectious disease diagnostics.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Supplemental Agreement for work within scope | ($137k) | 2/14/22 | |
| Not listed | Not listed | $225.8k | 10/1/20 |